PGP and cancer: Indeed, a fundamental observation driving the initiative to develop a semi-synthetic Salmonella nanoparticle mimic is the observation that SipA appears to be broad spectrum since this effector protein is able to modulate P-gp expression in several cancers that are known to over-express P-gp (for example, colon, kidney, breast and lymphoma).